Opdivo® clinical trials

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

This study looks at new drug combinations for advanced bowel cancer that hasn't spread widely. Researchers want to see if adding ONO-4578 and Opdivo® to standard treatment helps more than standard treatment alone. It's for people whose cancer creates a specific protein called PD-L1.